Embark and Novo Nordisk enter collaboration to discover novel therapeutics for obesity and metabolic disease


To Receive daily job alerts, Enter your email address, and dont forget to verify the job alerts:

Delivered by FeedBurner

Novo NordiskEmbark Biotech ApS and Novo Nordisk A/S have entered into a research collaboration focusing on the discovery of novel treatments for obesity and its associated metabolic pathologies through mechanisms that increase energy expenditure.